Novo Holdings to Acquire Catalent for $63.50/Share at a Valuation of $16.5B
Portfolio Pulse from Benzinga Newsdesk
Novo Holdings is set to acquire Catalent, Inc. (NYSE:CTLT) for $63.50 per share, valuing the company at $16.5 billion. This all-cash transaction marks a significant move in the development and supply sector for patient treatments.
February 05, 2024 | 11:02 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Catalent, Inc. is being acquired by Novo Holdings for $63.50 per share, valuing the company at $16.5 billion in an all-cash deal.
The acquisition of Catalent by Novo Holdings at a premium price per share is likely to have a positive short-term impact on CTLT's stock price. The all-cash nature of the deal provides immediate liquidity to shareholders, and the premium valuation reflects positively on the company's worth and future prospects.
CONFIDENCE 90
IMPORTANCE 100
RELEVANCE 100